TRCT
PROF

Tower Research Capital (TRC)’s Profound Medical PROF Stock Holding History

Tower Research Capital (TRC)’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-365
Closed -$1.78K – 5487
2025
Q3 		$1.78K Buy
+365
New +$1.86K ﹤0.01% 4732
2025
Q1 		– Sell
-316
Closed -$2.37K – 5656
2024
Q4 		$2.37K Buy
+316
New +$2.43K ﹤0.01% 4855
2024
Q2 		– Sell
-103
Closed -$879 – 5940
2024
Q1 		$879 Sell
103
-312
-75% -$2.6K ﹤0.01% 5368
2023
Q4 		$3.52K Buy
+415
New +$3.94K ﹤0.01% 5069
2023
Q3 		– Sell
-3,004
Closed -$39.1K – 6167
2023
Q2 		$39.1K Buy
3,004
+2,688
+851% +$33.3K ﹤0.01% 2791
2023
Q1 		$3K Buy
+316
New +$3.66K ﹤0.01% 5227
2022
Q4 		– Sell
-3,100
Closed -$13K – 6259
2022
Q3 		$13K Buy
3,100
+1,047
+51% +$7.07K ﹤0.01% 4281
2022
Q2 		$15K Buy
2,053
+1,917
+1,410% +$15.2K ﹤0.01% 4086
2022
Q1 		$1K Sell
136
-127
-48% -$1.22K ﹤0.01% 5840
2021
Q4 		$3K Buy
+263
New +$3.28K ﹤0.01% 5477
2021
Q3 		– Sell
-530
Closed -$9K – 6076
2021
Q2 		$9K Buy
530
+473
+830% +$8.8K ﹤0.01% 4445
2021
Q1 		$1K Buy
+57
New +$1.37K ﹤0.01% 5204

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $395M AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Tower Research Capital (TRC)'s PROF Position: Q4 2025 in Review

Tower Research Capital (TRC) sold out of Profound Medical (PROF) in Q4 2025, closing a stake of 365 shares — an estimated $1.78K sold.

Tower Research Capital (TRC) first reported a position in PROF in Q1 2021 and held it in 12 quarters. The position peaked at $39.1K in Q2 2023. 63 funds tracked by Wall St. Rank hold PROF as of Q4 2025.

  • Tower Research Capital (TRC) reported no remaining Profound Medical position as of Q4 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 365 Profound Medical shares in Q4 2025, an estimated $1.78K.
  • Tower Research Capital (TRC) first reported a position in Profound Medical in Q1 2021 and held it in 12 quarters.
  • Tower Research Capital (TRC)'s Profound Medical position peaked at $39.1K in Q2 2023.
  • 63 funds tracked by Wall St. Rank held Profound Medical as of Q4 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2025, filed 17 Feb 2026.